摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-amine | 1157581-13-9

中文名称
——
中文别名
——
英文名称
(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-amine
英文别名
(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanamine
(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-amine化学式
CAS
1157581-13-9
化学式
C10H13NO2
mdl
MFCD06762019
分子量
179.22
InChiKey
ABUSRLBOAUOYSM-SSDOTTSWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    44.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL INHIBITOR
    申请人:Nippon Chemiphar Co., Ltd.
    公开号:EP3404021A1
    公开(公告)日:2018-11-21
    A compound represented by the following General Formula (I), a tautomer or a stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, is used as a voltage-dependent T-type calcium channel blocker: wherein A represents a fused ring which may have a substituent, the fused ring being composed of a 5-membered heteroaryl group or a 5-membered or 6-membered heterocyclic ring and a benzene ring or the like, the 5-membered heteroaryl group having one to three identical or different heteroatoms as a ring-constituting element(s) having at least one substituent such as an alkoxy group having 1 to 8 carbon atoms and substituted with 1 to 5 halogen atoms; R represents a hydrogen atom or the like; B represents CR5(Q1) or NQ2, herein Q1 represents a benzimidazole group which may have a substituent; Q2 represents an alkyl group having 1 to 8 carbon atoms which may have a substituent, a heteroaryl group which may have a substituent, or the like; R0, R1, R2, R3, R4, and R5 each represent a hydrogen atom or the like; and n and m each represent 0, 1, or 2, provide that n and m are not 0 and 2 at the same time.
    由以下通式(I)代表的化合物、该化合物的同系物或立体异构体、其药学上可接受的盐或其溶液可用作电压依赖性 T 型钙通道阻滞剂: 其中 A 代表可具有取代基的融合环,该融合环由 5 元杂芳基或 5 元或 6 元杂环和苯环或类似物组成,5 元杂芳基具有 1 至 3 个相同或不同的杂原子作为成环元素,具有至少一个取代基,例如具有 1 至 8 个碳原子并被 1 至 5 个卤素原子取代的烷氧基;R 代表氢原子或类似物;B 代表 CR5(Q1) 或 NQ2,其中 Q1 代表可能具有取代基的苯并咪唑基;Q2 代表可能具有取代基的具有 1 至 8 个碳原子的烷基、可能具有取代基的杂芳基或类似物;R0、R1、R2、R3、R4 和 R5 各代表氢原子或类似物;n 和 m 各代表 0、1 或 2,但 n 和 m 不能同时为 0 和 2。
  • VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL BLOCKER
    申请人:Nippon Chemiphar Co., Ltd.
    公开号:US20190077767A1
    公开(公告)日:2019-03-14
    A compound represented by the following General Formula (I), a tautomer or a stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, is used as a voltage-dependent T-type calcium channel blocker: wherein A represents a fused ring which may have a substituent, the fused ring being composed of a 5-membered heteroaryl group or a 5-membered or 6-membered heterocyclic ring and a benzene ring or the like, the 5-membered heteroaryl group having one to three identical or different heteroatoms as a ring-constituting element(s) having at least one substituent such as an alkoxy group having 1 to 8 carbon atoms and substituted with 1 to 5 halogen atoms; R represents a hydrogen atom or the like; B represents CR5(Q1) or NQ2, herein Q1 represents a benzimidazole group which may have a substituent; Q2 represents an alkyl group having 1 to 8 carbon atoms which may have a substituent, a heteroaryl group which may have a substituent, or the like; R0, R1, R2, R3, R4, and R5 each represent a hydrogen atom or the like; and n and m each represent 0, 1, or 2, provide that n and m are not 0 and 2 at the same time.
查看更多

同类化合物

顺式-6-氯-4-甲基-4-苯基-4H-1,3-苯并二氧杂环己-2-羧酸 阿莫齐特 苯并二氧六环-6-甲酸甲酯 苯并二氧六环-6-甲酰胺 苯并二氧六环-5-甲酸甲酯 苯并二氧六环-5-甲酰胺 苯并二氧六环-2-磺酰氯 苯并-1,4-二氧六环-6-硼酸 艾泽罗西 胍苯克生 胍美柳 胍生 羧基-6-苯并(4H)二恶英-1,3 美商陆酚A 维兰特罗杂质4 盐酸艾美洛沙 盐酸哌罗克生 盐酸[(7-溴-2,3-二氢-1,4-苯并二恶英-6-基)甲基]肼 甲基氨基甲酸1,4-苯并二恶烷-5-基酯 甲基8-甲基-2,3-二氢-1,4-苯并二氧杂环己烷-6-羧酸酯 甲基7-甲基-2,3-二氢-1,4-苯并二氧杂环己烷-5-羧酸酯 甲基4-[(1E)-3-乙基-3-(羟甲基)三氮杂-1-烯-1-基]苯酸酯 甲基-[2-[(7-丙-2-烯基-2,3-二氢-1,4-苯并二氧杂环己-8-基)氧基]乙基]氯化铵 甲基(2S,4R)-6-氯-4-甲基-4-(2-噻吩基)-4H-1,3-苯并二氧杂环己烷-2-羧酸酯 溴(2,3-二氢-1,4-苯并二氧杂环己-6-基)镁 沙丁胺醇缩丙酮 异戊苯恶烷 度莫辛 布他莫生 安必罗山 地奥地洛 哌扑罗生 咪洛克生 咪唑克生盐酸盐 吡啶-3-磺酰氯盐酸盐 叔丁基 (2,3-二氢苯并[b][1,4]二噁英-6-基)氨基甲酸酯 反式-2,3-二氢-N-((4-(2-苯氧基乙基)-1-哌嗪基)甲基)-1,4-苯并二氧六环-2-甲酰胺 双恶哌嗪 冰达卡醇 依利格鲁司特中间体5 依利格鲁司特 亚达唑散 二氨基亚甲基-(2,3-二氢-1,4-苯并二氧杂环己-2-基甲基)铵硫酸盐 二-(叔丁基)2-(2,2-二甲基-4H-1,3-苯并二恶英-6-基)-2-氧代乙基亚氨基二碳酸 二(吡咯烷甲基)-4-羟基苯基乙酸1,4-苯并二噁烷基-2-甲基酯 乙基2,3-二氢-1,4-苯并二氧杂环己-6-基(氧代)乙酸酯 三氟甲烷磺酸7-甲氧基-2,2-二甲基-4-氧代-4H-1,3-苯并二氧杂环己-5-基酯 alpha-[[N-(2-甲氧基乙基)甲基氨基]甲基]-1,4-苯并二恶烷-2-甲醇 alpha-[[(4-甲氧基丁基)甲基氨基]甲基]-1,4-苯并二恶烷-2-甲醇 alpha-[[(4-甲氧基丁基)氨基]甲基]-alpha-甲基-1,4-苯并二恶烷-2-甲醇